Skip to main content
. 2010 Nov 30;104(2):338–344. doi: 10.1038/sj.bjc.6606025

Figure 4.

Figure 4

Prognostic value of cPLA2α expression on the overall survival of 295 breast cancer patients. Kaplan–Meier analysis of the probability of overall survival among (A) all 295 breast cancer patients (high n=45 vs low n=112), or patients with (B) basal (high n=23 vs low n=31) and (C) luminal cancers (high n=13 vs low n=62), according to cPLA2α expression. Survival curves were compared with the Cox-Mantel log-rank test, and the corresponding P-value is indicated.